🌟🌟🌟Investing in Chinese innovative drug companies represents a high conviction bet on a structural shift in China. The country is rapidly transitioning from a generic drug manufacturer into a global biopharma innovation powerhouse.
For investors looking to tap into this explosive trend without picking single volatile stocks, $DACHENG HANG SENG HEALTHCARE TRADING OPEN INDEX SECURITIES INVESTMENT FUND (QDII)(159303)$ and $E FUND HANG SENG HONG KONG STOCK CONNECT INNOVATIVE DRUG TRADING OPEN ENDED INDEX SECURITIES INVESTMENT FUND(159316)$ offer direct diversified gateways.
I believe both these ETFs have exponential growth ahead.
@Tiger_comments @TigerStars @Tiger_SG
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments